Letter to the Editor Regarding ‘Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerl...

por Muñoz, Manuel, Reinisch, Walter
Publicado 2021

Adverse Events Related to SARS-CoV-2 Vaccine in a Nationwide Cohort of Patients With Inflammatory Bowel Disease

por Mahmud, Nadim, Reinisch, Walter, Patel, Manthankumar, Sundararajan, Ramaswamy, Khan, Nabeel
Publicado 2022

Incidence of Long COVID and Impact of Medications on the Risk of Developing Long COVID in a Nationwide Cohort of IBD Patients

por Khan, Nabeel, Mahmud, Nadim, Patel, Manthankumar, Sundararajan, Ramaswamy, Reinisch, Walter
Publicado 2023

Risk factors for SARS-CoV-2 infection and course of COVID-19 disease in patients with IBD in the Veterans Affair Healthcare System

por Khan, Nabeel, Mahmud, Nadim, Trivedi, Chinmay, Reinisch, Walter, Lewis, James D
Publicado 2021

Low Occurrence of Colectomy With Long-Term (up to 4 Years) Golimumab Treatment in Patients With Moderate-to-Severe Active Ulcerative Colitis: Data From the PURSUIT Maintenance and...

por Weinstein, Cindy L J, Meehan, Alan G, Govoni, Marinella, Lin, Jianxin, Reinisch, Walter
Publicado 2023

Increased Induction Infliximab Clearance Predicts Early Antidrug Antibody Detection

por Eser, Alexander, Reinisch, Walter, Schreiber, Stefan, Ahmad, Tariq, Boulos, Suliman, Mould, Diane R.
Publicado 2020

Model Informed Precision Dosing Tool Forecasts Trough Infliximab and Associates with Disease Status and Tumor Necrosis Factor-Alpha Levels of Inflammatory Bowel Diseases

por Primas, Christian, Reinisch, Walter, Panetta, John C., Eser, Alexander, Mould, Diane R., Dervieux, Thierry
Publicado 2022

Inflammatory Bowel Disease Patients’ Perspectives of Clinical Trials: A Global Quantitative and Qualitative Analysis

por Rubin, David T, Peyrin-Biroulet, Laurent, Reinisch, Walter, Tole, Swati, Sullivan, Laura, Park, K T, Regueiro, Miguel
Publicado 2021

Risk for development of inflammatory bowel disease under inhibition of interleukin 17: A systematic review and meta-analysis

por Burisch, Johan, Eigner, Wolfgang, Schreiber, Stefan, Aletaha, Daniel, Weninger, Wolfgang, Trauner, Michael, Reinisch, Walter, Narula, Neeraj
Publicado 2020

External Model Performance Evaluation of Twelve Infliximab Population Pharmacokinetic Models in Patients with Inflammatory Bowel Disease

por Schräpel, Christina, Kovar, Lukas, Selzer, Dominik, Hofmann, Ute, Tran, Florian, Reinisch, Walter, Schwab, Matthias, Lehr, Thorsten
Publicado 2021

Tofacitinib in the treatment of ulcerative colitis: A position paper issued by the Inflammatory Bowel Disease Working Group of the Austrian Society of Gastroenterology and Hepatolo...

por Kutschera, Maximilian, Novacek, Gottfried, Reinisch, Walter, Högenauer, Christoph, Petritsch, Wolfgang, Haas, Thomas, Moschen, Alexander, Dejaco, Clemens
Publicado 2022

Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease (PHOSPHARE-IBD): a randomised...

por Zoller, Heinz, Wolf, Myles, Blumenstein, Irina, Primas, Christian, Lindgren, Stefan, Thomsen, Lars L, Reinisch, Walter, Iqbal, Tariq
Publicado 2023

A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel disease

por Reinisch, Walter, Altorjay, Istvan, Zsigmond, Ferenc, Primas, Christian, Vogelsang, Harald, Novacek, Gottfried, Reinisch, Sieglinde, Thomsen, Lars L.
Publicado 2015

Burden and outcomes for complex perianal fistulas in Crohn’s disease: Systematic review

por Panes, Julian, Reinisch, Walter, Rupniewska, Ewa, Khan, Shahnaz, Forns, Joan, Khalid, Javaria Mona, Bojic, Daniela, Patel, Haridarshan
Publicado 2018

Fr498 NEW GASTROINTESTINAL SYMPTOMS ARE COMMON IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH COVID-19: DATA FROM AN INTERNATIONAL REGISTRY

por Ungaro, Ryan C., Agrawal, Manasi, Brenner, Erica J., Zhang, Xian, Colombel, Jean Frederic, Kappelman, Michael, Reinisch, Walter
Publicado 2021

A Review of the Totality of Evidence for the Development and Approval of ABP 710 (AVSOLA), an Infliximab Biosimilar

por Reinisch, Walter, Cohen, Stanley, Ramchandani, Monica, Khraishi, Majed, Liu, Jennifer, Chow, Vincent, Franklin, Janet, Colombel, Jean-Frederic
Publicado 2021

The impact of ustekinumab on extraintestinal manifestations of Crohn's disease: A post hoc analysis of the UNITI studies

por Narula, Neeraj, Aruljothy, Achuthan, Wong, Emily C. L., Homenauth, Ravi, Alshahrani, Abdul‐Aziz, Marshall, John K., Reinisch, Walter
Publicado 2021

Course of Fecal Calprotectin after mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Diseases

por Pokryszka, Jagoda, Wagner, Angelika, Wiedermann, Ursula, Tobudic, Selma, Herkner, Harald, Winkler, Stefan, Brehovsky, Sonja, Reinisch, Walter, Novacek, Gottfried
Publicado 2022

Impact of COVID-19 Pandemic on Initiation of Immunosuppressive Treatment in Immune-Mediated Inflammatory Diseases in Austria: A Nationwide Retrospective Study

por Kutschera, Maximilian, Ritschl, Valentin, Reichardt, Berthold, Stamm, Tanja, Kiener, Hans, Maier, Harald, Reinisch, Walter, Benka, Bernhard, Novacek, Gottfried
Publicado 2022

A Randomized, Open-Label, Non-Inferiority Study of Intravenous Iron Isomaltoside 1,000 (Monofer) Compared With Oral Iron for Treatment of Anemia in IBD (PROCEED)

por Reinisch, Walter, Staun, Michael, Tandon, Rakesh K, Altorjay, Istvan, Thillainayagam, Andrew V, Gratzer, Cornelia, Nijhawan, Sandeep, Thomsen, Lars L
Publicado 2013